Case Study

Strategic pricing clarity unlocks value for immunology diagnostics innovator

See how a real-world pricing strategy for a novel multiplex immunology test helped the company proceed with confidence 

OPPORTUNITY/ISSUE

Entering uncharted territory with a first-in-class solution can be challenging.

A global IVD company wanted to enter the immunology diagnostics space with a unique multiplex test. But without any directly comparable offerings in the market, the company was struggling to price its new solution.  

Each of the launch markets – the US, the UK, Germany, and Italy – had its own challenges, including distinct reimbursement policies, purchasing behaviors, and clinical expectations. The client needed a clear understanding of how the test would be valued across these target markets to develop a pricing strategy that was both competitive and commercially viable.  

We stepped in to deliver that clarity by defining pricing potential and building a strategy that balanced market appeal and long-term profitability.  

one
APPROACH/SOLUTION

The client needed structured market insights to shape its pricing decisions.

Therefore, we focused our research on four core areas:

  • Reimbursement analysis: Analyzed existing reimbursement levels for immunology diagnostics and clarified estimated average reimbursements per test per country.  
  • Competitive price mapping: Examined real-world pricing for existing tests to understand what labs across different customer segments - academic labs, community labs, reference labs - were currently paying.
  • Perceived value assessment: Collected detailed stakeholder feedback to gauge the solution’s strengths, weaknesses, and relative performance versus incumbents.  
  • Willingness to pay modeling: Assessed pricing across both out-of-pocket and reimbursed settings, incorporating lab margin expectations and premium pricing potential across different segments. 
two
OUTCOME/RESULT

We provided market-specific pricing recommendations backed by strong analysis.

Our evidence-based strategy gave the client a pricing roadmap tailored to each country’s reimbursement structure and commercial environment. This also helped the company understand where to focus launch efforts, how to engage decision-makers, and what evidence would support future pricing. 

three
Kontakt

Nehmen Sie Kontakt zu uns auf, unser Team berät Sie gerne.